Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Umweltmedizin - Neue Erkenntnisse aus Wissenschaft und Praxis (2017) Schmitz-Spanke S, Nesseler T, Letzel S, Nowak D Edited Volume Increased prevalence of posttraumatic stress disorder in CRPS (2017) Speck V, Schlereth T, Birklein F, Maihöfner C Journal article A prospective, multisite, international validation of the Complex Regional Pain Syndrome Severity Score (2017) Harden RN, Maihofner C, Abousaad E, Vatine JJ, Kirsling A, Perez RSGM, Kuroda M, et al. Journal article Prerequisites, skills and productivity of young academic urologists in Germany (2017) Borgmann H, Bruendl J, Huber J, Ruf C, Schagdarsurgengin U, Wullich B, Salem J Journal article Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey (2017) Klein E, Beckmann M, Bader W, Brucker C, Dobos G, Fischer D, Hanf V, et al. Journal article Major coronary evaginations following implantation of bioresorbable vascular scaffolds: clinical and OCT characteristics (2017) Blachutzik F, Achenbach S, Röther J, Tröbs M, Schneider R, Weissner M, Schlundt C, Marwan M Conference contribution H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study (2017) Maurer M, Staubach P, Raap U, Richter-Huhn G, Bauer A, Rueff F, Jakob T, et al. Journal article Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017) Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al. Journal article Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors (2017) Doerffel Y, Kullmann F, Lammert F, Quietzsch D, Schöfl C, Schuppert F, Weber M, et al. Conference contribution Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition (2017) Heppt M, Heinzerling L, Kaehler K, Forschner A, Kirchberger M, Loquai C, Meissner M, et al. Conference contribution